Clinical Trial Update: A Study Investigating the Concentrations of Darapladib in Blood and the Safety of This Compound in Healthy Japanese Men [Phase 1]

View source ↗

Summary

This Phase 1 study assesses how Darapladib concentrates in the blood and evaluates safety in healthy Japanese men.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• Darapladib (darapladib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Atherosclerosis | Phase 1 | Status: COMPLETED